Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Account Payables (2016 - 2026)

Seres Therapeutics (MCRB) has disclosed Change in Account Payables for 11 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 100.12% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, up 18.47% year-over-year, with the annual reading at -$2.4 million for FY2025, 18.47% up from the prior year.
  • Change in Account Payables hit $5000.0 in Q4 2025 for Seres Therapeutics, up from -$515000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $7.2 million in Q2 2022 to a low of -$6.5 million in Q1 2022.
  • Historically, Change in Account Payables has averaged -$267500.0 across 5 years, with a median of $21500.0 in 2024.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 908.86% in 2022 and later plummeted 1455.26% in 2025.
  • Year by year, Change in Account Payables stood at $4.6 million in 2021, then increased by 19.04% to $5.5 million in 2022, then crashed by 192.41% to -$5.0 million in 2023, then grew by 17.4% to -$4.2 million in 2024, then skyrocketed by 100.12% to $5000.0 in 2025.
  • Business Quant data shows Change in Account Payables for MCRB at $5000.0 in Q4 2025, -$515000.0 in Q3 2025, and $79000.0 in Q2 2025.